Stem, Inc.
STEM NYSE Services-Computer Integrated Systems Design Financials FY2019βFY2025
What Stem, Inc. does
No business description yet.
- Legal name
- STEM, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 5, 2026
- Accession Β· CIK
- 0001758766-26-000016
0001758766
Revenue and margins
Stem, Inc. had $156M of revenue in fiscal 2025, up 8.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Stem, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 5.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Stem, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $921M | $250M | $114M | $56.3M | $48.9M |
| Interest coverage | β4.8x | β12.5x | β12.0x | β45.9x | β2.3x |
| Current ratio | 11.6x | 2.0x | 1.9x | 1.1x | 0.9x |
| Quick ratio | 11.4x | 2.0x | 1.8x | 1.1x | 0.9x |
| Total assets | $1.2B | $1.4B | $1.4B | $437M | $309M |
| Total liabilities | $524M | $870M | $930M | $835M | $558M |
| Shareholders' equity | $668M | $552M | $426M | β$398M | β$249M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 3 / 8 | 3 / 8 | 2 / 8 | 1 / 8 | 5 / 8 |
| Accruals ratio | β11,753.4% | β118.8% | 0.0% | β1.4% | 4.8% | β91.1% | 35.1% |
| Altman Z'' | β1,382.00 | β13.06 | 4.63 | β0.18 | β1.19 | β25.41 | β17.62 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $17.6M | $36.3M | $127M | $363M | $462M | $145M | $156M |
| Gross profit | β$3.3M | β$3.9M | $1.2M | $33.1M | $3.7M | β$11.1M | $60.0M |
| Research and development | $14.7M | $15.9M | $22.7M | $38.3M | $56.5M | $51.3M | $35.3M |
| Operating income | β$47.9M | β$49.4M | β$83.1M | β$131M | β$179M | β$839M | β$55.7M |
| Interest expense | $12.5M | $20.8M | $17.4M | $10.5M | $15.0M | $18.3M | $23.9M |
| Pretax income | β$59.4M | β$156M | β$101M | β$139M | β$140M | β$854M | $138M |
| Income tax | $0.0M | $0.0M | $0.0M | β$15.2M | $0.4M | $0.3M | $0.5M |
| Net income | β$59.4M | β$156M | β$101M | β$124M | β$140M | β$854M | $138M |
| Net income to common | β$64.8M | β$166M | β$101M | β$124M | β$140M | β$854M | $138M |
| Diluted EPS | β$1.51 | β$4.13 | β$0.96 | β$0.81 | β$18.05 | β$105.80 | β$9.18 |
| Diluted shares | 0.04B | 0.04B | 0.11B | 0.15B | 0.01B | 0.01B | 0.01B |
| Cash flow | |||||||
| Cash from operations | β$29.7M | β$33.7M | β$101M | β$106M | β$207M | β$36.7M | $6.9M |
| Depreciation and amortization | $13.9M | $17.7M | $24.5M | $45.4M | $46.3M | $45.0M | $44.9M |
| Stock-based compensation | $1.5M | $4.5M | $13.5M | $28.7M | $45.1M | $18.5M | $10.2M |
| Acquisitions | β | $0.0M | $0.0M | $533M | $1.8M | $0.0M | $0.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $12.9M | $6.9M | $921M | $250M | $114M | $56.3M | $48.9M |
| Current assets | $0.0M | $49.3M | $1.0B | $533M | $473M | $137M | $100M |
| Current liabilities | $0.2M | $191M | $88.0M | $267M | $251M | $129M | $111M |
| Inventory | β | $20.8M | $22.7M | $8.4M | $26.7M | β | β |
| Property and equipment, net | β | $124M | $106M | $90.8M | $74.4M | $58.8M | $43.9M |
| Goodwill | β | $1.7M | $1.7M | $547M | $547M | $0.0M | $0.0M |
| Intangible assets | β | $12.1M | $14.0M | $162M | $157M | $144M | $123M |
| Total assets | $0.3M | $206M | $1.2B | $1.4B | $1.4B | $437M | $309M |
| Total liabilities | $0.2M | $383M | $524M | $870M | $930M | $835M | $558M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$24.5M | β$177M | $668M | $552M | $426M | β$398M | β$249M |
| Margins | |||||||
| Gross margin | β18.6% | β10.8% | 1.0% | 9.1% | 0.8% | β7.6% | 38.4% |
| Operating margin | β272.6% | β136.0% | β65.2% | β36.1% | β38.9% | β580.6% | β35.6% |
| EBITDA margin | β193.5% | β87.2% | β46.0% | β23.6% | β28.8% | β549.5% | β6.9% |
| Net margin | β338.5% | β430.0% | β79.5% | β34.2% | β30.4% | β590.7% | 88.2% |
| Returns | |||||||
| Return on capital employed | β747,656.3% | β322.1% | β7.5% | β11.4% | β16.2% | β272.1% | β28.1% |
| Return on equity | β | β | β41.3% | β20.3% | β28.7% | β6,139.1% | β |
| Return on assets | β23,483.8% | β151.5% | β14.5% | β9.5% | β10.1% | β95.2% | 36.9% |
| Return on tangible equity | β | β | β15.5% | β | β | β | β |
| Growth | |||||||
| Revenue growth | β | 106.9% | 250.8% | 185.0% | 27.1% | β68.7% | 8.1% |
| Share count change | β | β6.4% | 163.5% | 45.3% | β94.9% | 3.8% | 5.2% |
| Financial health | |||||||
| Interest coverage | β3.8x | β2.4x | β4.8x | β12.5x | β12.0x | β45.9x | β2.3x |
| Current ratio | 0.0x | 0.3x | 11.6x | 2.0x | 1.9x | 1.1x | 0.9x |
| Quick ratio | 0.0x | 0.1x | 11.4x | 2.0x | 1.8x | 1.1x | 0.9x |
| Capital allocation | |||||||
| Stock comp / revenue | 8.7% | 12.5% | 10.6% | 7.9% | 9.8% | 12.8% | 6.5% |
| Quality scores | |||||||
| Piotroski F-score | β | 5.0 | 3.0 | 3.0 | 2.0 | 1.0 | 5.0 |
| Altman Z'' | β1,382.0 | β13.1 | 4.6 | β0.2 | β1.2 | β25.4 | β17.6 |
| Accruals ratio | β11,753.4% | β118.8% | 0.0% | β1.4% | 4.8% | β91.1% | 35.1% |
Source: SEC EDGAR XBRL filings (CIK 0001758766). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.